Industries > Pharma > Next-Generation Cancer Diagnostics Market Forecast 2017-2027

Next-Generation Cancer Diagnostics Market Forecast 2017-2027

Next-Generation Sequencing (NGS), Microarray, Circulating Tumour Cells (CTCs) Analysis, In Situ Hybridization (ISH), Advanced PCR Techniques

PUBLISHED: 10 May 2017
PAGES: 166
PRODUCT CODE: PHA0192

Clear
WOOCS 2.2.1

The next-generation cancer diagnostics market is expected to grow at a CAGR of 16.5% in the first half of the forecast period and CAGR of 19.1% in the second half of the forecast period. The market is estimated at $1.9bn in 2016 and $4.1bn in 2021.

While the number of new cancer cases is expected to reach 24 million by 2035, the cost savings that could be achieved with early diagnosis will be the main driver for the market. Advances in molecular biology will also help expand the cancer diagnostics test menu.

Companion cancer diagnostics can be costly but we expect them to be increasingly adopted, particularly when choosing expensive cancer therapies. Laboratory automation, standardised commercial cancer tests and affordable benchtop instruments will continue to reduce the costs of molecular testing.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 87 charts – all unavailable elsewhere.

The 166-page report provides clear detailed insight into the next-generation cancer diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Next-Generation Cancer Diagnostics Market Forecast 2017-2027

Report Scope
Forecasts and analysis of the next-generation cancer diagnostics market from 2017 to 2027.

• 5 next-generation cancer diagnostics submarkets forecast and analysis from 2017 to 2027:
– Advanced PCR Techniques
– In Situ Hybridization (ISH)
– Circulating Tumour Cells (CTCs) Analysis
– Microarray
– Next-Generation Sequencing (NGS)

• Revenue forecasts for 8 leading national or regional next-generation cancer diagnostics market from 2017 to 2027:
– US
– EU5
– Japan
– China
– India
– Brazil
– Russia
– Rest of the World

• Assessment of selected leading companies marketing next-generation cancer diagnostics, examining recent performance and outlooks:
– Roche Diagnostics
– Abbott Laboratories
– Qiagen
– Thermo Fisher Scientific
– Agilent Technologies
– Hologic
– Illumina
– Myriad Genetics

SWOT analysis of the next-generation cancer diagnostics market, and discusses some current trends.

Visiongain’s study is intended for anyone requiring commercial analyses for the next-generation cancer diagnostics market. You find data, trends and predictions.

Buy our report today Next-Generation Cancer Diagnostics Market Forecast 2017-2027: Next-Generation Sequencing (NGS), Microarray, Circulating Tumour Cells (CTCs) Analysis, In Situ Hybridization (ISH), Advanced PCR Techniques.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Cancer Diagnostics Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Next-Generation Cancer Diagnostics Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

READ

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

READ

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

READ

Categories